While in OI patients, the HYL levels were consistently higher in bone-derived collagen-I compared to fibroblasts-derived, in control individuals HYL levels were lower in bone-derived samples (Supplementary Fig. S1). This evidence concerns the gene MATK and osteogenesis imperfecta.